These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 12654953)

  • 1. Progression of gait, speech and swallowing deficits in progressive supranuclear palsy.
    Goetz CG; Leurgans S; Lang AE; Litvan I
    Neurology; 2003 Mar; 60(6):917-22. PubMed ID: 12654953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical features and natural history of progressive supranuclear palsy: a clinical cohort study.
    Nath U; Ben-Shlomo Y; Thomson RG; Lees AJ; Burn DJ
    Neurology; 2003 Mar; 60(6):910-6. PubMed ID: 12654952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding the relationship between freezing of gait and other progressive supranuclear palsy features.
    Rezvanian S; Litvan I; Standaert D; Jankovic J; Reich SG; Hall D; Shprecher DR; Bordelon Y; Dubinsky R; Kluger B
    Parkinsonism Relat Disord; 2020 Sep; 78():56-60. PubMed ID: 32731191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterizing swallowing abnormalities in progressive supranuclear palsy.
    Litvan I; Sastry N; Sonies BC
    Neurology; 1997 Jun; 48(6):1654-62. PubMed ID: 9191782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Progressive supranuclear palsy].
    Goetz CG
    Rev Neurol (Paris); 2003 May; 159(5 Pt 2):3S25-9. PubMed ID: 12773885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progressive supranuclear palsy presenting as primary lateral sclerosis but lacking parkinsonism, gaze palsy, aphasia, or dementia.
    Nagao S; Yokota O; Nanba R; Takata H; Haraguchi T; Ishizu H; Ikeda C; Takeda N; Oshima E; Sakane K; Terada S; Ihara Y; Uchitomi Y
    J Neurol Sci; 2012 Dec; 323(1-2):147-53. PubMed ID: 23026537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progressive supranuclear palsy: progression and survival.
    Arena JE; Weigand SD; Whitwell JL; Hassan A; Eggers SD; Höglinger GU; Litvan I; Josephs KA
    J Neurol; 2016 Feb; 263(2):380-389. PubMed ID: 26705121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of survival in a series of clinically diagnosed progressive supranuclear palsy patients.
    dell'Aquila C; Zoccolella S; Cardinali V; de Mari M; Iliceto G; Tartaglione B; Lamberti P; Logroscino G
    Parkinsonism Relat Disord; 2013 Nov; 19(11):980-5. PubMed ID: 23968651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of allied health therapy in the symptomatic management of progressive supranuclear palsy: a systematic review.
    Tilley E; McLoughlin J; Koblar SA; Doeltgen SH; Stern C; White S; Peters MD
    JBI Database System Rev Implement Rep; 2016 Jun; 14(6):148-95. PubMed ID: 27532657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysphagia in Progressive Supranuclear Palsy.
    Clark HM; Stierwalt JAG; Tosakulwong N; Botha H; Ali F; Whitwell JL; Josephs KA
    Dysphagia; 2020 Aug; 35(4):667-676. PubMed ID: 31676923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study.
    Litvan I; Mangone CA; McKee A; Verny M; Parsa A; Jellinger K; D'Olhaberriague L; Chaudhuri KR; Pearce RK
    J Neurol Neurosurg Psychiatry; 1996 Jun; 60(6):615-20. PubMed ID: 8648326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcomes of progressive supranuclear palsy and multiple system atrophy.
    O'Sullivan SS; Massey LA; Williams DR; Silveira-Moriyama L; Kempster PA; Holton JL; Revesz T; Lees AJ
    Brain; 2008 May; 131(Pt 5):1362-72. PubMed ID: 18385183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Features of Patients With Nonfluent/Agrammatic Primary Progressive Aphasia With Underlying Progressive Supranuclear Palsy Pathology or Corticobasal Degeneration.
    Santos-Santos MA; Mandelli ML; Binney RJ; Ogar J; Wilson SM; Henry ML; Hubbard HI; Meese M; Attygalle S; Rosenberg L; Pakvasa M; Trojanowski JQ; Grinberg LT; Rosen H; Boxer AL; Miller BL; Seeley WW; Gorno-Tempini ML
    JAMA Neurol; 2016 Jun; 73(6):733-42. PubMed ID: 27111692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deep brain stimulation of the pedunculopontine nucleus for treatment of gait and balance disorder in progressive supranuclear palsy: Effects of frequency modulations and clinical outcome.
    Galazky I; Kaufmann J; Lorenzl S; Ebersbach G; Gandor F; Zaehle T; Specht S; Stallforth S; Sobieray U; Wirkus E; Casjens F; Heinze HJ; Kupsch A; Voges J
    Parkinsonism Relat Disord; 2018 May; 50():81-86. PubMed ID: 29503154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Communication impairments in people with progressive supranuclear palsy: A tutorial.
    Kim JH; McCann CM
    J Commun Disord; 2015; 56():76-87. PubMed ID: 26184056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acoustical analysis of speech in progressive supranuclear palsy.
    Skodda S; Visser W; Schlegel U
    J Voice; 2011 Nov; 25(6):725-31. PubMed ID: 20457507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bilateral pedunculopontine nucleus stimulation for progressive supranuclear palsy.
    Doshi PK; Desai JD; Karkera B; Wadia PM
    Stereotact Funct Neurosurg; 2015; 93(1):59-65. PubMed ID: 25662728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative Gait Analysis in Progressive Supranuclear Palsy and Parkinson's Disease.
    Hatanaka N; Sato K; Hishikawa N; Takemoto M; Ohta Y; Yamashita T; Abe K
    Eur Neurol; 2016; 75(5-6):282-9. PubMed ID: 27288001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroimaging comparison of primary progressive apraxia of speech and progressive supranuclear palsy.
    Whitwell JL; Duffy JR; Strand EA; Machulda MM; Senjem ML; Gunter JL; Kantarci K; Eggers SD; Jack CR; Josephs KA
    Eur J Neurol; 2013 Apr; 20(4):629-37. PubMed ID: 23078273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Progressive Supranuclear Palsy Clinical Deficits Scale.
    Piot I; Schweyer K; Respondek G; Stamelou M; ; ; ; Sckopke P; Schenk T; Goetz CG; Stebbins GT; Höglinger GU
    Mov Disord; 2020 Apr; 35(4):650-661. PubMed ID: 31951049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.